ConductScience.org, home

Paper39796644

Prognostic Value of Molecular Aberrations in Low- or Intermediate-Risk Neuroblastomas: A Systematic Review.

Bruinsma RS and 9 others. Cancers (Basel), 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Prognostic Value of Molecular Aberrations in Low- or Intermediate-Risk Neuroblastomas: A Systematic Review. Papers, record 39796644. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39796644

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic Value of Molecular Aberrations in Low- or Intermediate-Risk Neuroblastomas: A Systematic Review.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.34, provisional
iCite
Revised in PubMed
2025-01-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bruinsma RSRixt Shttps://orcid.org/0000-0001-8557-4529
2Lekkerkerker CWMCaroline W M
3Fiocco MMartahttps://orcid.org/0000-0001-5588-0277
4Dierselhuis MPMiranda P
5Langenberg KPSKarin P Shttps://orcid.org/0000-0002-6780-0585
6Tytgat GAMGodelieve A Mhttps://orcid.org/0000-0003-4452-0748
7van Noesel MMMax M
8Wijnen MHWAMarc H W A
9van der Steeg AFWAlida F Whttps://orcid.org/0000-0003-0168-7513
10de Krijger RRRonald Rhttps://orcid.org/0000-0001-6871-1296

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120516441Accumulation of segmental alterations determines progression in neuroblastoma.J Clin Oncol2010https://conductscience.org/library/papers/20516441PubMed
226864375Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.Pediatr Blood Cancer2016https://conductscience.org/library/papers/26864375PubMed
329296183Identification of the genetic and clinical characteristics of neuroblastomas using genome-wide analysis.Oncotarget2017https://conductscience.org/library/papers/29296183PubMed
418478485Risk estimation of neuroblastoma patients using molecular markers.Klin Padiatr2008https://conductscience.org/library/papers/18478485PubMed
515591897New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status.J Pediatr Hematol Oncol2004https://conductscience.org/library/papers/15591897PubMed
625775931Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients.BMJ2015https://conductscience.org/library/papers/25775931PubMed
722146831Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).Br J Cancer2011https://conductscience.org/library/papers/22146831PubMed
816306521Chromosome 1p and 11q deletions and outcome in neuroblastoma.N Engl J Med2005https://conductscience.org/library/papers/16306521PubMed
910561284Molecular biology of neuroblastoma.J Clin Oncol1999https://conductscience.org/library/papers/10561284PubMed
1012764740FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.Med Pediatr Oncol2003https://conductscience.org/library/papers/12764740PubMed
1134636058Neuroblastoma-Telomere maintenance, deregulated signaling transduction and beyond.Int J Cancer2022https://conductscience.org/library/papers/34636058PubMed
1229378002Neuroblastoma.Jpn J Clin Oncol2018https://conductscience.org/library/papers/29378002PubMed
1320879880Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.N Engl J Med2010https://conductscience.org/library/papers/20879880PubMed
1410379019Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.N Engl J Med1999https://conductscience.org/library/papers/10379019PubMed
1522529259Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.J Clin Oncol2012https://conductscience.org/library/papers/22529259PubMed
1619047291The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.J Clin Oncol2009https://conductscience.org/library/papers/19047291PubMed
1719171713Overall genomic pattern is a predictor of outcome in neuroblastoma.J Clin Oncol2009https://conductscience.org/library/papers/19171713PubMed
1822976801Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.Br J Cancer2012https://conductscience.org/library/papers/22976801PubMed
1916549855Evaluation of the quality of prognosis studies in systematic reviews.Ann Intern Med2006https://conductscience.org/library/papers/16549855PubMed
2035100718Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in Neuroblastoma.JCO Precis Oncol2019https://conductscience.org/library/papers/35100718PubMed

See all 41 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
41733731Identification of potential clinical markers associated with prognosis of neuroblastoma.Discov Oncol2026https://conductscience.org/library/papers/41733731PubMed
41595154Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk.Cancers (Basel)2026https://conductscience.org/library/papers/41595154PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39796644

GET https://conductscience.org/api/papers/v1/39796644/references?page=2